|
|
||||||||
1 Department of Large Animal Clinical Sciences and
2 Department of Animal Science, Michigan State University, East Lansing, 48824
Corresponding author: R. J. Erskine; e-mail: erskine{at}cvm.msu.edu.
Isotype-specific antibody responses and cross reactivity were profiled following hyperimmunization of steers with J5 Escherichia coli bacterin. The vaccine was administered at time 0, 30 d later, and every 2 wk for 10 subsequent immunizations. Blood was collected preimmunization and multiple times following each immunization. Isotype-specific anti-J5 Escherichia coli antibody response profiles in diluted sera harvested from each sample were assayed by ELISA and recorded as optical density. Selected sera were assayed for anti-J5 Escherichia coli antibody titers and used to determine cross reactivity against a variety of gram-negative bacteria. Immunization number and day postimmunization influenced response profiles for anti-J5 E. coli IgM, IgG1and IgG2 antibodies. Two immunizations increased mean serum IgM and the IgG1antibody profiles above preimmunization levels, but 5 immunizations were required to detect significant IgG2 antibody responses that were above preimmunization levels. Isotype-specific cross reactivity of the serum antibodies with a variety of heterologous gram-negative bacteria was also increased by hyperimmunization. However, no cross reactivity was observed for Staphylococcus aureus, purified lipopolysaccharide, or lipid A. Our results indicate that multiple booster doses of J5 E. coli bacterin may be required to elicit high levels of cross-reactive serum IgG2 antibodies.
Key Words: J5 Escherichia coli hyperimmunization antibody response cross reactivity
Abbreviation key: FBS = fetal bovine serum, INF-
= interferon-gamma, OD = optical density, OMP = outer membrane protein, TSB = trypticase soy broth.
This article has been cited by other articles:
![]() |
D. J. Wilson, B. A. Mallard, J. L. Burton, Y. H. Schukken, and Y. T. Grohn Association of Escherichia coli J5-Specific Serum Antibody Responses with Clinical Mastitis Outcome for J5 Vaccinate and Control Dairy Cattle Clin. Vaccine Immunol., February 1, 2009; 16(2): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Wilson, B. A. Mallard, J. L. Burton, Y. H. Schukken, and Y. T. Grohn Milk and Serum J5-Specific Antibody Responses, Milk Production Change, and Clinical Effects following Intramammary Escherichia coli Challenge for J5 Vaccinate and Control Cows Clin. Vaccine Immunol., June 1, 2007; 14(6): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |